Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 65, Issue 4, 2001, Pages 191-196

  Hishinuma, T ^a   Tsukamoto, H ^a   Suzuki, K ^b   Mizugaki, M ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b Tohokukoseinenkin Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; PROSTACYCLIN; THROMBOXANE A2; THROMBOXANE B2;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ION MONITORING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035667435     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0310     Document Type: Article

References (31)

1. The eicosanoids and their biochemical mechanisms of action
2. Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders
3. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation
4. Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: Abnormalities in diabetics
5. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes
6. 2/prostacyclin ratio in urine of diabetic mice analyzed by gas chromatography/selected ion monitoring
7. 2/prostacyclin balance reflects the pathological state of diabetic
8. 2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method
9. 2
10. 2) in aqueous solutions
11. Biosynthesis and pharmacological modulation of thromboxane in humans
12. 2 formation in the human circulation
13. 1α levels: Influence of sampling techniques
14. 1α in human urine gas chromatography-high-resolution selected ion monitoring
15. 2-labelled analogue as an internal standard
16. Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus
17. Diacylglycerol accumulation and microsvascular abnormalities induced by elevated glucose levels
18. Identification of PKC-isoform-specific biological actions using pharmacological approaches
19. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose
20. Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats
21. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase
22. Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester
23. Selective eicosanoid formation during HL-60 macrophage differentiation. Regulation of thromboxane synthase
24. Aldose reductase inhibitors and their potential for the treatment of diabetic complications
25. 3 by cultured bovine aortic endothelial cells
26. Reduced expression of a novel peptide, prostacyclin-stimulating factor, in the kidneys of streptozotocin-induced diabetic rats
27. Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy
28. Effects of low density and high density lipoproteins isolated from non-insulin dependent diabetic patients on prostaglandin secretion by mouse macrophage cell line P388D1
29. Low density lipoprotein undergoes oxidative modification in vivo
30. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
31. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: A randomized prospective 6-year study